{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:40:15Z","timestamp":1792683615127,"version":"4.5.0"},"reference-count":89,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcehepatology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical and Experimental Hepatology"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.jceh.2021.08.016","type":"journal-article","created":{"date-parts":[[2021,8,21]],"date-time":"2021-08-21T02:00:15Z","timestamp":1629511215000},"page":"186-199","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"title":["Diagnosis and Management of Cirrhotic Cardiomyopathy"],"prefix":"10.1016","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7653-3271","authenticated-orcid":false,"given":"Harpreet","family":"Kaur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2961-4148","authenticated-orcid":false,"given":"Madhumita","family":"Premkumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jceh.2021.08.016_bib1","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/hep.27598","article-title":"The clinical course of cirrhosis: the importance of multistate models and competing risks analysis","volume":"62","author":"Jepsen","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2021.08.016_bib2","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.jceh.2018.08.008","article-title":"Left ventricular diastolic dysfunction is associated with renal dysfunction, poor survival and low health related quality of life in cirrhosis","volume":"9","author":"Premkumar","year":"2019","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2021.08.016_bib3","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1136\/gut.2006.112177","article-title":"Cardiovascular complications of cirrhosis","volume":"57","author":"M\u00f8ller","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.jceh.2021.08.016_bib4","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/lt.24768","article-title":"Cirrhotic cardiomyopathy: implications for liver transplantation","volume":"23","author":"Liu","year":"2017","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jceh.2021.08.016_bib5","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1093\/ehjci\/jew082","article-title":"Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American society of echocardiography and the European association of cardiovascular imaging","volume":"17","author":"Nagueh","year":"2016","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.jceh.2021.08.016_bib6","doi-asserted-by":"crossref","DOI":"10.1590\/1414-431x20187809","article-title":"Cirrhotic cardiomyopathy: the liver affects the heart","volume":"52","author":"Carvalho","year":"2019","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.jceh.2021.08.016_bib7","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1097\/MCG.0000000000000323","article-title":"High rate of cardiac abnormalities in a postmortem analysis of patients suffering from liver cirrhosis","volume":"49","author":"Wehmeyer","year":"2015","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.jceh.2021.08.016_bib8","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1665-2681(19)31544-3","article-title":"Anatomical cardiac alterations in liver cirrhosis: an autopsy study","volume":"10","author":"Ortiz-Olvera","year":"2011","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.jceh.2021.08.016_bib9","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/hep.30875","article-title":"Redefining cirrhotic cardiomyopathy for the modern era","volume":"71","author":"Izzy","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2021.08.016_bib10","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/hep.20766","article-title":"Circulatory function and hepatorenal syndrome in cirrhosis","volume":"42","author":"Ruiz-del-Arbol","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2021.08.016_bib11","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1136\/gut.2009.180570","article-title":"Low cardiac output predicts development of hepatorenal syndrome and survival in patients with cirrhosis and ascites","volume":"59","author":"Krag","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.jceh.2021.08.016_bib12","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1002\/hep.30040","article-title":"Cirrhotic cardiomyopathy after transplantation: neither the transient nor innocent bystander","volume":"68","author":"Izzy","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2021.08.016_bib13","doi-asserted-by":"crossref","first-page":"673","DOI":"10.3892\/mmr.2017.6643","article-title":"Farnesoid X receptor deletion improves cardiac function, structure and remodeling following myocardial infarction in mice","volume":"16","author":"Gao","year":"2017","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.jceh.2021.08.016_bib14","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1111\/liv.13394","article-title":"Bile acids and cardiovascular function in cirrhosis","volume":"37","author":"Voiosu","year":"2017","journal-title":"Liver Int"},{"key":"10.1016\/j.jceh.2021.08.016_bib15","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1161\/ATVBAHA.107.152694","article-title":"Farnesoid x receptor ligands inhibit vascular smooth muscle cell inflammation and migration","volume":"27","author":"Li","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jceh.2021.08.016_bib16","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0016-5085(00)70180-6","article-title":"Contribution of nitric oxide to the pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated rats","volume":"118","author":"Liu","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2021.08.016_bib17","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1136\/heartjnl-2013-304163","article-title":"Bile acids induce arrhythmias in human atrial myocardium--implications for altered serum bile acid composition in patients with atrial fibrillation","volume":"99","author":"Rainer","year":"2013","journal-title":"Heart"},{"key":"10.1016\/j.jceh.2021.08.016_bib18","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/jgh3.12166","article-title":"Noninvasive estimation of intravascular volume status in cirrhosis by dynamic size and collapsibility indices of the inferior vena cava using bedside echocardiography","volume":"3","author":"Premkumar","year":"2019","journal-title":"JGH Open"},{"key":"10.1016\/j.jceh.2021.08.016_bib19","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1177\/0885066620988281","article-title":"Point-of-Care echocardiography and hemodynamic monitoring in cirrhosis and acute-on-chronic liver failure in the COVID-19 era","volume":"36","author":"Premkumar","year":"2021","journal-title":"J\u00a0Intensive Care Med"},{"key":"10.1016\/j.jceh.2021.08.016_bib20","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s12072-017-9784-3","article-title":"Microalbuminuria, systemic inflammation, and multiorgan dysfunction in decompensated cirrhosis: evidence for a nonfunctional mechanism of hepatorenal syndrome","volume":"11","author":"Arroyo","year":"2017","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jceh.2021.08.016_bib21","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.jhep.2018.02.007","article-title":"Hepatic and cardiac hemodynamics and systemic inflammation in cirrhosis: it takes three to tango","volume":"68","author":"Coenraad","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2021.08.016_bib22","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1007\/s10620-015-3752-3","article-title":"Cirrhotic multiorgan syndrome","volume":"60","author":"M\u00f8ller","year":"2015","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jceh.2021.08.016_bib23","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/s41575-018-0045-2","article-title":"Novel perspectives in the management of decompensated cirrhosis","volume":"15","author":"Bernardi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2021.08.016_bib24","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.jhep.2017.12.027","article-title":"Cardiopulmonary hemodynamics and C-reactive protein as prognostic indicators in compensated and decompensated cirrhosis","volume":"68","author":"Turco","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2021.08.016_bib25","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1007\/s10620-013-2693-y","article-title":"Frequency and severity of cirrhotic cardiomyopathy and its possible relationship with bacterial endotoxemia","volume":"58","author":"Karagiannakis","year":"2013","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jceh.2021.08.016_bib26","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1161\/CIRCRESAHA.119.313572","article-title":"Heart failure with preserved ejection fraction in perspective","volume":"124","author":"Pfeffer","year":"2019","journal-title":"Circ Res"},{"key":"10.1016\/j.jceh.2021.08.016_bib27","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1136\/heartasia-2011-010023","article-title":"Liver diseases in heart failure","volume":"3","author":"Maleki","year":"2011","journal-title":"Heart Asia"},{"key":"10.1016\/j.jceh.2021.08.016_bib28","first-page":"44","article-title":"Cardiovascular complications of cirrhosis","volume":"85","author":"M\u00f8ller","year":"2009","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.jceh.2021.08.016_bib29","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.jhep.2018.01.006","article-title":"Cirrhotic cardiomyopathy","volume":"69","author":"M\u00f8ller","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2021.08.016_bib30","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.jhep.2018.08.009","article-title":"Corrigendum to \"EASL clinical practice guidelines for the management of patients with decompensated cirrhosis\" [J Hepatol 69 (2018) 406-460]","volume":"69","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2021.08.016_bib31","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1136\/gut.49.2.268","article-title":"The cardiac response to exercise in cirrhosis","volume":"49","author":"Wong","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.jceh.2021.08.016_bib32","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1097\/MEG.0b013e32833a4822","article-title":"Effects of a single terlipressin administration on cardiac function and perfusion in cirrhosis","volume":"22","author":"Krag","year":"2010","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2021.08.016_bib33","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12968-015-0157-6","article-title":"Assessment of cardiovascular physiology using dobutamine stress cardiovascular magnetic resonance reveals impaired contractile reserve in patients with cirrhotic cardiomyopathy","volume":"17","author":"Sampaio","year":"2015","journal-title":"J\u00a0Cardiovasc Magn Reson"},{"key":"10.1016\/j.jceh.2021.08.016_bib34","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/j.1478-3231.2011.02468.x","article-title":"Resting myocardial dysfunction in cirrhosis quantified by tissue Doppler imaging","volume":"31","author":"Kazankov","year":"2011","journal-title":"Liver Int"},{"key":"10.1016\/j.jceh.2021.08.016_bib35","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1002\/ejhf.879","article-title":"Epidemiology, pathophysiology and clinical outcomes for heart failure patients with a mid-range ejection fraction","volume":"19","author":"Rastogi","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jceh.2021.08.016_bib36","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1002\/hep.26509","article-title":"Diastolic dysfunction is a predictor of poor outcomes in patients with cirrhosis, portal hypertension, and a normal creatinine","volume":"58","author":"Ru\u00edz-del-\u00c1rbol","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2021.08.016_bib37","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.mehy.2012.03.032","article-title":"The cardiorenal link in advanced cirrhosis","volume":"79","author":"Krag","year":"2012","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.jceh.2021.08.016_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000492791","article-title":"Hepatorenal syndrome or Hepatocardiorenal syndrome: revisiting basic concepts in view of emerging data","volume":"9","author":"Kazory","year":"2019","journal-title":"Cardiorenal Med"},{"key":"10.1016\/j.jceh.2021.08.016_bib39","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/MCG.0000000000001219","article-title":"Carvedilol combined with ivabradine improves left ventricular diastolic dysfunction, clinical progression, and survival in cirrhosis","volume":"54","author":"Premkumar","year":"2020","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.jceh.2021.08.016_bib40","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1111\/liv.13870","article-title":"Myocardial extracellular volume quantified by magnetic resonance is increased in cirrhosis and related to poor outcome","volume":"38","author":"Wiese","year":"2018","journal-title":"Liver Int"},{"key":"10.1016\/j.jceh.2021.08.016_bib41","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1432-2277.2011.01219.x","article-title":"High brain-natriuretic peptide level predicts cirrhotic cardiomyopathy in liver transplant patients","volume":"24","author":"Saner","year":"2011","journal-title":"Transpl Int"},{"key":"10.1016\/j.jceh.2021.08.016_bib42","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jhep.2011.02.030","article-title":"Role of cardiac myofilament proteins titin and collagen in the pathogenesis of diastolic dysfunction in cirrhotic rats","volume":"55","author":"Glenn","year":"2011","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2021.08.016_bib43","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1055\/s-2008-1040321","article-title":"Cirrhotic cardiomyopathy","volume":"28","author":"Alqahtani","year":"2008","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jceh.2021.08.016_bib44","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/s12072-014-9544-6","article-title":"Diastolic cardiac dysfunction is a predictor of dismal prognosis in patients with liver cirrhosis","volume":"8","author":"Karagiannakis","year":"2014","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jceh.2021.08.016_bib45","first-page":"1131","article-title":"Evidence of functional and structural cardiac abnormalities in cirrhotic patients with and without ascites","volume":"26","author":"Pozzi","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2021.08.016_bib46","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jhep.2012.08.027","article-title":"LEFT ventricular function assessed by echocardiography in cirrhosis: relationship to systemic hemodynamics and renal dysfunction","volume":"58","author":"Nazar","year":"2013","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2021.08.016_bib47","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/hep.29520","article-title":"Cardiovascular predictors of death in patients with cirrhosis","volume":"68","author":"Cesari","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2021.08.016_bib48","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/liv.13287","article-title":"Survival at 2 years among liver cirrhotic patients is influenced by left atrial volume and left ventricular mass","volume":"37","author":"Merli","year":"2017","journal-title":"Liver Int"},{"key":"10.1016\/j.jceh.2021.08.016_bib49","doi-asserted-by":"crossref","first-page":"126","DOI":"10.4103\/jcecho.jcecho_6_17","article-title":"The role of ivabradine in diastolic heart failure with preserved ejection fraction. A Doppler-echocardiographic study","volume":"27","author":"Cacciapuoti","year":"2017","journal-title":"J\u00a0Cardiovasc Echogr"},{"key":"10.1016\/j.jceh.2021.08.016_bib50","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1001\/archinte.1958.00030010405009","article-title":"A\u00a0study of heart disease in one hundred eight hospitalized patients dying with portal cirrhosis","volume":"102","author":"Lunseth","year":"1958","journal-title":"AMA Arch Intern Med"},{"key":"10.1016\/j.jceh.2021.08.016_bib51","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1080\/17474124.2019.1587293","article-title":"An update on cirrhotic cardiomyopathy","volume":"13","author":"M\u00f8ller","year":"2019","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2021.08.016_bib52","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/0002-8703(92)90518-Z","article-title":"Differentiation between primary dilated cardiomyopathy and ischemic cardiomyopathy based on right ventricular performance","volume":"123","author":"Iskandrian","year":"1992","journal-title":"Am Heart J"},{"key":"10.1016\/j.jceh.2021.08.016_bib53","doi-asserted-by":"crossref","first-page":"G275","DOI":"10.1152\/ajpgi.00094.2017","article-title":"Transjugular intrahepatic portosystemic shunt: impact on systemic hemodynamics and renal and cardiac function in patients with cirrhosis","volume":"314","author":"Busk","year":"2018","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jceh.2021.08.016_bib54","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1136\/gut.2006.102467","article-title":"Diastolic dysfunction is associated with poor survival in patients with cirrhosis with transjugular intrahepatic portosystemic shunt","volume":"56","author":"Cazzaniga","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.jceh.2021.08.016_bib55","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1038\/ajg.2009.321","article-title":"The use of E\/A ratio as a predictor of outcome in cirrhotic patients treated with transjugular intrahepatic portosystemic shunt","volume":"104","author":"Rabie","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jceh.2021.08.016_bib56","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/MEG.0b013e32835d09fe","article-title":"Cardiac and renal effects of a transjugular intrahepatic portosystemic shunt in cirrhosis","volume":"25","author":"Busk","year":"2013","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2021.08.016_bib57","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1572-0241.2002.05438.x","article-title":"Modifications of cardiac function in cirrhotic patients treated with transjugular intrahepatic portosystemic shunt (TIPS)","volume":"97","author":"Merli","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jceh.2021.08.016_bib58","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jhep.2010.11.003","article-title":"The heart in liver transplantation","volume":"54","author":"Ripoll","year":"2011","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2021.08.016_bib59","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1016\/j.amjcard.2012.08.021","article-title":"Role of baseline echocardiography in the preoperative management of liver transplant candidates","volume":"110","author":"Harinstein","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jceh.2021.08.016_bib60","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.4254\/wjh.v7.i23.2432","article-title":"Transoesophageal echocardiography during liver transplantation","volume":"7","author":"De Pietri","year":"2015","journal-title":"World J Hepatol"},{"key":"10.1016\/j.jceh.2021.08.016_bib61","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1002\/lt.20298","article-title":"Cardiac morbidity and mortality related to orthotopic liver transplantation","volume":"10","author":"Therapondos","year":"2004","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jceh.2021.08.016_bib62","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1097\/TP.0b013e31825f0f97","article-title":"Diastolic dysfunction in patients with end-stage liver disease is associated with development of heart failure early after liver transplantation","volume":"94","author":"Dowsley","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2021.08.016_bib63","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jhep.2004.09.008","article-title":"Cardiac alterations in cirrhosis: reversibility after liver transplantation","volume":"42","author":"Torregrosa","year":"2005","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2021.08.016_bib64","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1053\/jlts.2002.34381","article-title":"Cardiac function after orthotopic liver transplantation and the effects of immunosuppression: a prospective randomized trial comparing cyclosporin (Neoral) and tacrolimus","volume":"8","author":"Therapondos","year":"2002","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jceh.2021.08.016_bib65","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/ctr.12778","article-title":"Impact and persistence of cirrhotic cardiomyopathy after liver transplantation","volume":"30","author":"Sonny","year":"2016","journal-title":"Clin Transplant"},{"key":"10.1016\/j.jceh.2021.08.016_bib66","doi-asserted-by":"crossref","first-page":"11502","DOI":"10.3748\/wjg.v21.i41.11502","article-title":"Cirrhotic cardiomyopathy","volume":"21","author":"Ruiz-del-\u00c1rbol","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jceh.2021.08.016_bib67","first-page":"140","article-title":"A\u00a0detailed evaluation of cardiac function in cirrhotic patients and its alteration with or without liver transplantation","volume":"67","author":"Chen","year":"2016","journal-title":"J\u00a0Cardiol"},{"key":"10.1016\/j.jceh.2021.08.016_bib68","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.3748\/wjg.14.3445","article-title":"Cardiac evaluation of liver transplant candidates","volume":"14","author":"Mandell","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jceh.2021.08.016_bib69","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/j.metabol.2016.02.013","article-title":"Non-alcoholic fatty liver disease and liver transplantation","volume":"65","author":"Khan","year":"2016","journal-title":"Metabolism"},{"key":"10.1016\/j.jceh.2021.08.016_bib70","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1002\/hep.25855","article-title":"Patients transplanted for nonalcoholic steatohepatitis are at increased risk for postoperative cardiovascular events","volume":"56","author":"Vanwagner","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2021.08.016_bib71","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4103\/0019-5049.174870","article-title":"Preoperative cardiovascular investigations in liver transplant candidate: an update","volume":"60","author":"Sehgal","year":"2016","journal-title":"Indian J Anaesth"},{"key":"10.1016\/j.jceh.2021.08.016_bib72","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1586\/egh.11.86","article-title":"QT interval prolongation in liver cirrhosis: innocent bystander or serious threat?","volume":"6","author":"Bernardi","year":"2012","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2021.08.016_bib73","first-page":"31","article-title":"Cardiovascular dysfunction in patients with liver cirrhosis","volume":"28","author":"Fede","year":"2015","journal-title":"Ann Gastroenterol"},{"key":"10.1016\/j.jceh.2021.08.016_bib74","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.jhep.2005.04.015","article-title":"Prolonged Q-T(c) interval in mild portal hypertensive cirrhosis","volume":"43","author":"Ytting","year":"2005","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2021.08.016_bib75","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1080\/00365510601182634","article-title":"Q-T interval (QT(C)) in patients with cirrhosis: relation to vasoactive peptides and heart rate","volume":"67","author":"Henriksen","year":"2007","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.jceh.2021.08.016_bib76","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1111\/j.1478-3231.2012.02847.x","article-title":"QT interval prolongation by acute gastrointestinal bleeding in patients with cirrhosis","volume":"32","author":"Trevisani","year":"2012","journal-title":"Liver Int"},{"key":"10.1016\/j.jceh.2021.08.016_bib77","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.amjcard.2004.10.054","article-title":"Effect of cirrhosis and liver transplantation on the gender difference in QT interval","volume":"95","author":"Adigun","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jceh.2021.08.016_bib78","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.transproceed.2010.12.002","article-title":"Alterations in QT interval in patients undergoing living donor liver transplantation","volume":"43","author":"Shin","year":"2011","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jceh.2021.08.016_bib79","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jhep.2003.10.026","article-title":"Acute non-selective beta-adrenergic blockade reduces prolonged frequency-adjusted Q-T interval (QTc) in patients with cirrhosis","volume":"40","author":"Henriksen","year":"2004","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2021.08.016_bib80","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jhep.2007.11.012","article-title":"Effect of chronic beta-blockade on QT interval in patients with liver cirrhosis","volume":"48","author":"Zambruni","year":"2008","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2021.08.016_bib81","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1097\/MEG.0000000000001128","article-title":"\u03b2-Blocker therapy for cirrhotic cardiomyopathy: a randomized-controlled trial","volume":"30","author":"Silvestre","year":"2018","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2021.08.016_bib82","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1002\/hep.30204","article-title":"Clinical consequences of cardiomyopathy in children with biliary atresia requiring liver transplantation","volume":"69","author":"Gorgis","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2021.08.016_bib83","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1007\/s12072-015-9674-5","article-title":"Cardiac abnormalities in cirrhotic children: pre- and post-liver transplantation","volume":"10","author":"Khemakanok","year":"2016","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jceh.2021.08.016_bib84","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1136\/gut.52.10.1511","article-title":"Increased circulating pro-brain natriuretic peptide (proBNP) and brain natriuretic peptide (BNP) in patients with cirrhosis: relation to cardiovascular dysfunction and severity of disease","volume":"52","author":"Henriksen","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.jceh.2021.08.016_bib85","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/MEG.0b013e3282fb7cd0","article-title":"Validity of N-terminal propeptide of the brain natriuretic peptide in predicting left ventricular diastolic dysfunction diagnosed by tissue Doppler imaging in patients with chronic liver disease","volume":"20","author":"Raedle-Hurst","year":"2008","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2021.08.016_bib86","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1111\/liv.12428","article-title":"Cardiac and proinflammatory markers predict prognosis in cirrhosis","volume":"34","author":"Wiese","year":"2014","journal-title":"Liver Int"},{"key":"10.1016\/j.jceh.2021.08.016_bib87","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.116.004815","article-title":"Cardiac remodeling in patients with primary and secondary aldosteronism: a tissue Doppler study","volume":"9","author":"Cesari","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jceh.2021.08.016_bib88","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0140-6736(10)61198-1","article-title":"Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study","volume":"376","author":"Swedberg","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jceh.2021.08.016_bib89","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s11894-020-00783-1","article-title":"Cirrhotic cardiomyopathy","volume":"22","author":"Yoon","year":"2020","journal-title":"Curr Gastroenterol Rep"}],"container-title":["Journal of Clinical and Experimental Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688321002218?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688321002218?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T06:07:22Z","timestamp":1760854042000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0973688321002218"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":89,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S0973688321002218"],"URL":"https:\/\/doi.org\/10.1016\/j.jceh.2021.08.016","relation":{},"ISSN":["0973-6883"],"issn-type":[{"value":"0973-6883","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnosis and Management of Cirrhotic Cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical and Experimental Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jceh.2021.08.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}